OA-20X

OA-20X is a proprietary series of formulations developed by Ampio Pharmaceuticals for the treatment of osteoarthritis (OA), particularly targeting osteoarthritis of the knee. The drug candidate is based on prior research into OA therapies and has demonstrated promising results in preclinical rodent models, showing both cartilage protection and pain reduction. These new formulations are distinct from earlier products by Ampio and are being advanced toward clinical development. The mechanism of action has not been fully disclosed but centers on anti-inflammatory effects, cartilage preservation, and analgesia in OA[8][1][2].